Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. Juni 2017 09:01 ET | Quelle: Prevacus, Inc.

Prevacus Inc., Announces the Addition of Randy Travis to its Advisory Board

TALLAHASSEE, Fla., June 26, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
22. Februar 2017 10:15 ET | Quelle: Prevacus, Inc.

Prevacus Announces the Addition of Key Individuals to its Sports Advisory Board

TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
15. Februar 2017 08:00 ET | Quelle: Prevacus, Inc.

Prevacus Announces Appearance on Fox Business

TALLAHASSEE, Fla., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
09. Februar 2017 16:01 ET | Quelle: Prevacus, Inc.

Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion

TALLAHASSEE, Fla., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion aka mild Traumatic Brain Injury (mTBI) and...